EYPT:NASDAQ
EyePoint Inc
$4.58
arrow_upward
+0.33%(+0.015) 1D
$4.58
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 4, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EYPT...
Open
$4.53
High
$4.69
Low
$4.48
Mkt. cap
394.42M
Avg. vol.
5.31M
Volume
1.90M
52-wk high
$19.01
52-wk low
$3.95
EPS
-$3.74
Beta
1.63
Shares outstanding
86.21M
No. of employees
214
Open
$4.53
High
$4.69
Low
$4.48
Mkt. cap
394.42M
Avg. vol.
5.31M
Volume
1.90M
52-wk high
$19.01
52-wk low
$3.95
EPS
-$3.74
Beta
1.63
Shares outstanding
86.21M
No. of employees
214
News stories
From web sources and news partners
GlobeNewswire
·
1 day ago
EyePoint, Inc. (NASDAQ: EYPT) Alert: Investors Encouraged to Contact KTMC Law Firm
Yahoo Finance
·
1 day ago
EyePoint (EYPT) Stock Sees Fair Value Cut After Split Analyst Revisions On LUGANO
Profile
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems and nanotechnology to drug delivery.
pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency. QinetiQ continues to be a strategic partner.
In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc. Wikipedia
About EyePoint Inc
CEO-
Employees214
Founded2000
HeadquartersWatertown, Massachusetts, United States
SectorPharmaceutical industry
Websiteeyepoint.bio